Online Courses
Study in China
About Beijing
News & Events
Clinical Study on Treatment of Hyperlipidemia with Shanhuang Jiangzhi
Objective: To explore the effect of Shanhuang Jiangzhi Tablet (SJT), a preparation for reducing blood lipid, in the treatment of hyperlipidemia.
Methods: 600 cases of Hyperlipidemia were divided randomly into the treatment group (n=500), and the control group A and B (50 cases each), They were treated with SJT Alginic Sodium Diester and Gypenoside tablet respectively, and observed.
Result: In the treatment group, the serum cholesterol (TC), triglyceride (TG) decreased and high-density lipoprotein cholestero1 (HDL-C) increased markedly, the difference was significantly as compared with the control groups (P<0.00l). The total effective rate in the treatment group was 99.2%, while that in the control group A was 52% and group B 72%, the difference between the treatment group and the control group was significant (P<0.00l).
Conclusion: The lipid reducing effect of SJT is obviously superior to that of the control group, and is an ideal for the treatment of hyperlipidemia.
(By Yu Baofeng, Qian Chunlan, From China-Mongo1ia Hospital, Hulunbel League, Halal, Inner Mongo1ia 02l000, China)